Synthesis, Biological Evaluation of 1,1-Diarylethylenes as a Novel Class of Antimitotic Agents

✍ Scribed by Abdallah Hamze; Anne Giraud; Samir Messaoudi; Olivier Provot; Jean-François Peyrat; Jérôme Bignon; Jian-Miao Liu; Joanna Wdzieczak-Bakala; Sylviane Thoret; Joëlle Dubois; Jean-Daniel Brion; Mouad Alami

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 805 KB
• Volume: 4
• Category: Article
• ISSN: 1860-7179
• DOI: 10.1002/cmdc.200900290

✦ Synopsis

Abstract

The cytotoxic activities of 23 new iso__combretastatin A derivatives with modifications on the B‐ring were investigated. Several compounds exhibited excellent antiproliferative activity at nanomolar concentrations against a panel of human cancer cell lines. Compounds__ iso__FCA‐4 (2 e),__ iso__CA‐4 (2 k) and__ iso__NH~2~CA‐4 (2 s) were the most cytotoxic, and strongly inhibited tubulin polymerization with IC~50~ values of 4, 2 and 1.5 μM, respectively. These derivatives were found to be 10‐fold more active than phenstatin and colchicine with respect to growth inhibition but displayed similar activities as tubulin polymerization inhibitors. In addition, cell cycle arrest in the G~2~/M phase and subsequent apoptosis was observed in three cancer cell lines when treated with these compounds. The disruptive effect of 2 e, 2 k and 2 s on the vessel‐like structures formed by human umbilical vein endothelial cells (HUVEC) suggest that these compounds may act as vascular disrupting agents. Both compounds 2 k and 2 s have the potential for further prodrug modification and development as vascular disrupting agents for treatment of solid tumors.__